AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Armata Pharmaceuticals, Inc. Director's Dealing 2005

Nov 2, 2005

34152_dirs_2005-11-02_2aa4041e-1398-4ca1-a539-29466b744dda.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: TARGETED GENETICS CORP /WA/ (TGEN)
CIK: 0000921114
Period of Report: 2005-10-31

Reporting Person: PERRY MICHAEL S (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	0	Direct